Collegium Pharmaceutical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell COLL and other ETFs, options, and stocks.

About COLL

Collegium Pharmaceutical, Inc. is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. The firm has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions. 

CEO
Vikram Karnani
CEOVikram Karnani
Employees
423
Employees423
Headquarters
Stoughton, Massachusetts
HeadquartersStoughton, Massachusetts
Founded
2002
Founded2002
Employees
423
Employees423

COLL Key Statistics

Market cap
775.47M
Market cap775.47M
Price-Earnings ratio
19.28
Price-Earnings ratio19.28
Dividend yield
—
Dividend yield—
Average volume
560.09K
Average volume560.09K
High today
$24.50
High today$24.50
Low today
$23.66
Low today$23.66
Open price
$24.28
Open price$24.28
Volume
388.27K
Volume388.27K
52 Week high
$50.79
52 Week high$50.79
52 Week low
$21.43
52 Week low$21.43

Stock Snapshot

As of today, Collegium Pharmaceutical(COLL) shares are valued at $23.80. The company's market cap stands at 775.47M, with a P/E ratio of 19.28.

As of 2026-11-01, Collegium Pharmaceutical(COLL) stock has fluctuated between $23.66 and $24.50. The current price stands at $23.80, placing the stock +0.6% above today's low and -2.9% off the high.

The Collegium Pharmaceutical(COLL)'s current trading volume is 388.27K, compared to an average daily volume of 560.09K.

In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $50.79 and a 52-week low of $21.43.

In the last year, Collegium Pharmaceutical(COLL) shares hit a 52-week high of $50.79 and a 52-week low of $21.43.

COLL News

Simply Wall St 4d
Collegium Pharmaceutical (Nasdaq:COLL) - Stock Analysis - Simply Wall St

...

Collegium Pharmaceutical (Nasdaq:COLL) - Stock Analysis - Simply Wall St

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

People also own

Based on the portfolios of people who own COLL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.